Zions: Q3 Earnings Snapshot

Nasdaq rose 1.11% while Dow slipped 0.07%, with S&P 500 up 0.66%. VIX fell 1.55 points. Lockheed Martin delivered a C-130J-30 to the U.S. Navy. F.N.B. reported Q3 net income of $152.9M. Haemonetics got FDA approval for PerQseal Elite. Zions Bancorporation Q3 earnings rose 20% YoY. Crown Holdings Q3 EPS up to $2.08.

Zions Bancorporation (ZION) reported Q3 2026 earnings per share (EPS) exceeding estimates, but missed on tangible book value per share (TBVPS) and net interest income. TBVPS grew 14.6% annually over the last two years and is expected to rise 17.5% in the next 12 months. The stock price increased 1.2% to $63.88 post-results.

Zions (ZION) reported Q3 EPS of $1.78, beating estimates by $0.12, but revenue of $881M fell slightly short. Stock is down 8.70% in 3 months but up 21.47% in 12 months. InvestingPro rates its financial health as 'good performance.'

Zions Bancorp reported 3Q26 net earnings of $262M, up from $221M in 3Q25, with diluted EPS of $1.78. Net interest income was $684M, and the CET1 ratio rose to 11.8%. Loans and deposits grew by 4% year-over-year, while nonperforming assets declined.

Zions Bancorporation reported Q3 GAAP EPS of $1.78, exceeding estimates by $0.12. Revenue was $881M, up 1.0% year-over-year but missing expectations by $10.93M.

Zions Bancorporation reported Q3 2026 net earnings of $262M, up from $221M in Q3 2025. CEO Harris Simmons attributed the increase to improved credit quality and deposit growth. The bank completed the acquisition of Basis Multifamily Finance I, LLC, and expects stronger net interest income in a higher rate environment.